Incidental primary breast cancer detected on surveillance 68Ga-DOTATATE PET/CT in a patient with metastatic neuroendocrine carcinoma

Incidental primary breast cancer detected on surveillance 68Ga-DOTATATE PET/CT in a patient with metastatic neuroendocrine carcinoma

We present a case of a 53-year-old woman with metastatic neuroendocrine tumor, presumed primary in the small intestine with metastases to the liver and mesenteric lymph nodes. The patient was being treated with lanreotide and followed with somatostatin receptor (SSTR)-targeted 68Ga-labeled 1,4,7,10-...

Full description

Bibliographic Details
Main Authors: Emily B. Ambinder, MD, Rudolf A. Werner, MD, Steven P. Rowe, MD, PhD
Format: Article
Language:English
Published: Elsevier 2020-08-01
Series:Radiology Case Reports
Subjects:
Breast neoplasm
Dotatate PET/CT
Somatostatin receptor imaging
Neuroendocrine carcinoma
Online Access:http://www.sciencedirect.com/science/article/pii/S1930043320302302

Similar Items

Similar Items